Tissue engineering and regenerative medicine

2024 Activity indicator

  • 1 public competitive project led: ISCIII
  • 5 private projects led
  • 2 clinical studies led
  • 3 competitive HR contracts
  • 47 publications
  • IF: 184.90
  • Q1 publications: 26 (55%)
  • D1 publications: 5 (11%)
  • 11 thesis
  • 1 recognition to a member of the group
  • Evaluators in international public agencies: 2 researchers
  • Evaluators in national public agencies: 3 researchers
  • Member of editorial committees: 2 researchers

Milestones

  1. European patent application (EP23382390.5) 'Method for monitoring the spatial deviation with respect to a planned surgical procedure' with PCT/EP2024/061573.
  2. Consolidation of the MITIC-CM Consortium of the Biomedicine R&D Activities Programme of the Community of Madrid (B2022/BMD-7321).
  3. A total of 11 doctoral theses supervised, which reaffirms the group's commitment, impact and influence on training and academic development. This effort has been recognised with a prestigious award for excellence in the supervision of doctoral theses.
  4. Participation and leadership in the MADRIDNIGHT Programme 'Researchers and citizens: facing together the European challenges'.
  5. High impact results of the public project PI21/01244 with the publication Muñoz-Chápuli Gutiérrez M, Prat AS, Vila AD, Claverol MB, Martínez PP, Recarte PP, Benéitez MV, García CA, Muñoz EC, Navarro M, Navarro PG, Álvarez-Mon M, Ortega MA, de León-Luís J. Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study. EClinicalMedicine. 2024 5;67:102398. doi: 10.1016/j.eclinm.2023.102398.

Bibliometrics

 
ARTICLES
ACCUM. FI
MEAN FI
ARTICLES Q1 OR Q2
% IN Q1 OR Q2
ARTICLES D1
% IN D1
2020 24 66.94 3.04 14 58 0 0
2021 52 212.05 4.16 44 85 3 6
2022 53 243.54 4.60 45 85 2 4
2023 55 277.97 4.60 44 80 10 18
2024 47 184.90 4.20 42 89 5 11
  231 985.40 4.12 189 82 20 9

* Only original articles, editorial material, guidelines and reviews.

Networks and alliances